Effect of ripasudil on diabetic macular edema
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-019-40194-5.pdf
Reference35 articles.
1. Ciulla, T. A., Amador, A. G. & Zinman, B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care. 26, 2653–2664 (2003).
2. Yau, J. W. et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 35, 556–564 (2012).
3. Fogli, S., Mogavero, S., Egan, C. G., Del Re, M. & Danesi, R. Pathophysiology and pharmacological targets of VEGF in diabetic macular edema. Pharmacol Res. 103, 149–157 (2016).
4. Mitchell, P. et al. The RESTORE study: Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 118, 615–625, https://doi.org/10.1016/j.ophtha.2011.01.031 (2011).
5. Elman, M. J. et al. Diabetic Retinopathy Clinical Research Network. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology. 119, 2312–2318, https://doi.org/10.1016/j.ophtha.2012.08.022 (2012).
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Rho-kinase Inhibitors in Ocular Diseases: A Translational Research Journey;Journal of Current Glaucoma Practice;2023-05-13
2. ROCK inhibitors in ophthalmology: A critical review of the existing clinical evidence;Clinical & Experimental Ophthalmology;2023-04-10
3. Rho-kinase inhibitors in pseudophakic cystoid macular edema with secondary glaucoma;Indian Journal of Ophthalmology - Case Reports;2023
4. Drugs for the treatment of glaucoma: Targets, structure-activity relationships and clinical research;European Journal of Medicinal Chemistry;2021-12
5. Intravitreal Fasudil for Treatment of Diabetic Macular Edema with an Unfavorable Response;Seminars in Ophthalmology;2021-08-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3